Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Nefrología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Multi-centric, Placebo-controlled, Participant and Investigator-blinded Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Adult Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.
INTERVENTIONAL
Inicio: 3 de mar de 2023
ID: NCT05524051
Completado
Fase 4
ClinicalTrials.gov
A Randomized, Controlled, Open-Label, Multi-Centre, Parallel-Group Study To Assess All-Cause Mortality And Cardiovascular Morbidity In Patients With Chronic Kidney Disease On Dialysis And Those Not On Renal Replacement Therapy Under Treatment With MIRCERA® Or Reference ESAs.
INTERVENTIONAL
Inicio: 12 de dic de 2008
ID: NCT00773513
Reclutando
Fase 2
ClinicalTrials.gov
An Adaptive, Randomized, Double-blind, Dose Exploration, Parallel Group, Placebo Controlled, Multicenter Phase 2 Trial to Evaluate the Efficacy, Safety and Tolerability of LNP023 in Combination With Standard-of-care With and Without Oral Corticosteroids in Patients With Active Lupus Nephritis Class III-IV, +/- V
INTERVENTIONAL
Inicio: 10 de ago de 2022
ID: NCT05268289
Reclutando
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled, Four-arm, Parallel-group, Dose-finding Phase 2b Study to Investigate the Safety and Efficacy of TIN816 Via a Single Intravenous Infusion in the Treatment of Participants With Sepsis-associated Acute Kidney Injury (CLEAR-AKI)
INTERVENTIONAL
Inicio: 18 de ene de 2024
ID: NCT05996835
Completado
Fase 3
ClinicalTrials.gov
An Open-Label Extension (OLE) Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Patients With IgA Nephropathy Who Have Completed Study Nef-301
INTERVENTIONAL
Inicio: 17 de nov de 2020
ID: NCT04541043
Terminado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Somatropin in Adult Patients on Chronic Haemodialysis
INTERVENTIONAL
Inicio: 1 de jul de 2007
ID: NCT00503698
Reclutando
Fase 2
ClinicalTrials.gov
ROSETTA RCC-208: A Phase 1/2 Open-label, Multi-center, Randomized Study of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC)
INTERVENTIONAL
Inicio: 26 de mar de 2026
ID: NCT07293351
Completado
Fase 3
ClinicalTrials.gov
A 24-month, Multi-center, Open-label, Randomized, Controlled Trial to Investigate Efficacy, Safety and Evolution of Cardiovascular Parameters in de Novo Renal Transplant Recipients After Early Calcineurin Inhibitor to Everolimus Conversion
INTERVENTIONAL
Inicio: 9 de ago de 2010
ID: NCT01114529
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Three Arm, Randomized, Open Label Clinical Study to Compare Renal Function in Liver Transplant Recipients Receiving an Immunosuppressive Regimen of Advagraf (Immediately or Delayed Post-transplant) and MMF With or Without a Monoclonal Anti-IL2R Antibody (Basiliximab)
INTERVENTIONAL
Inicio: 30 de sept de 2009
ID: NCT01011205
Terminado
Fase 3
ClinicalTrials.gov
A Phase II/III Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Versus Placebo on a Background of Mycophenolate Mofetil and Glucocorticosteroids in Subjects With Active Proliferative Glomerulonephritis Due to Systemic Lupus Erythematosus (SLE)
INTERVENTIONAL
Inicio: 1 de jun de 2007
ID: NCT00430677
Completado
Fase 1
ClinicalTrials.gov
A Phase 1 Study to Compare Bempegaldesleukin Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (mRCC) (PIVOT IO 011)
INTERVENTIONAL
Inicio: 11 de sept de 2020
ID: NCT04540705
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b, Randomized, Controlled Double-blind, Multicenter Study Comparing the Efficacy and Safety of Zetomipzomib (KZR-616) 30 mg or 60 mg With Placebo in Patients With Active Lupus Nephritis
INTERVENTIONAL
Inicio: 3 de nov de 2023
ID: NCT05781750
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
INTERVENTIONAL
Inicio: 19 de may de 2025
ID: NCT06830798
Completado
Fase 3
ClinicalTrials.gov
Study to Investigate the Clinical Outcomes of Different Regimens of Myfortic® in De Novo Kidney Tx Pts Using Simulect® and Neoral® With or Without Steroids
INTERVENTIONAL
Inicio: 1 de mar de 2003
ID: NCT00101738
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Multi-center, Open Label Study of NIR178 in Combination With PDR001 in Patients With Selected Advanced Solid Tumors and Non-Hodgkin Lymphoma
INTERVENTIONAL
Inicio: 28 de ago de 2017
ID: NCT03207867
Completado
Fase 2
ClinicalTrials.gov
Randomised, Double-blind (Within Dose Groups), Placebo-controlled and Parallel Group Trial to Investigate the Effects of Different Doses of Oral BI 685509 Given Over 20 Weeks on UACR Reduction in Patients With Diabetic Kidney Disease
INTERVENTIONAL
Inicio: 27 de abr de 2021
ID: NCT04750577
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Open-Label Study of Once Daily LY3502970 Compared With Insulin Glargine in Adult Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
INTERVENTIONAL
Inicio: 3 de abr de 2023
ID: NCT05803421
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Group, Multicenter, Multinational Safety and Efficacy Trial of 300 mg and 900 mg of Abetimus Sodium in Systemic Lupus Erythematosus (SLE) Patients With a History of Renal Disease
INTERVENTIONAL
Inicio: 1 de oct de 2004
ID: NCT00089804
Completado
Fase 2
ClinicalTrials.gov
Use of a Completely Autologous and Completely Biological Tissue Engineered Blood Vessel Lifeline as an Arteriovenous Fistula in Hemodialysis Patients - Safety and Efficacy Study.
INTERVENTIONAL
Inicio: 1 de sept de 2004
ID: NCT00850252
Completado
Fase 3
ClinicalTrials.gov
Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (INNO2VATE-CONVERSION)
INTERVENTIONAL
Inicio: 1 de ago de 2016
ID: NCT02892149
Anterior
1
...
13
14
15
...
434
Siguiente
Filtros